The Mounjaro Price Increase Petition: What UK Patients Are Asking — and What It Actually Changes

Did any petition stop the Mounjaro price increase?

No petition has changed Lilly's UK pricing. The list price rise that came into effect on 1 September 2025 stands, and private providers now purchase stock at the higher wholesale cost. Patient petitions (however understandable) have no binding mechanism over a manufacturer's pricing decisions. What they have done is keep the issue visible and push some providers to absorb part of the increase rather than pass it on in full. The gap between providers has widened as a result.

If you signed a petition or found your way here through one, the practical question is the same one you started with: what does treatment actually cost now, and what does that cost include? Those two questions matter more than the headline number. You can check any online pharmacy's legitimacy in about thirty seconds by searching for its name on the GPhC pharmacy register, a quick habit that costs nothing and tells you a great deal.

For a fuller account of how the price change came about and what it means dose by dose, the Mounjaro UK price increase page covers the background in detail.

What does a private Mounjaro price typically include, and what might it not?

Since the September 2025 list price change, typical private Mounjaro prices in the UK have ranged roughly £149–£375 per month depending on dose and provider, though these figures shift and should be treated as market context rather than fixed quotes, and you can find a current breakdown on our Mounjaro price page.

Some providers charge separately for the clinical consultation, the prescription itself, or delivery. Others bundle aftercare into a monthly subscription that continues regardless of whether your clinical needs change. A lower headline price can, in practice, become a higher total cost once those extras are added. Equally, a higher headline price at a provider that includes consultation, prescription, tracked delivery and ongoing clinical support may represent better overall value, and better safety.

Mounjaro's titration schedule starts at 2.5mg, a dose designed to let your system adjust rather than to produce maximum effect immediately, and moves upward as the prescriber judges appropriate. The 2.5mg price increase context explains how cost shifts at that specific entry point. Dose changes, of course, change the monthly cost too, so a quoted price at one dose tells you only part of the story.

Why doesn't nume compete on price, and what does that mean for you?

We don't enter the cheapest-price contest. That's a deliberate choice, not an oversight. When a manufacturer raises the list price of a prescription medicine by roughly 170%, some providers absorb part of the hit, some pass it straight on, and some find ways to trim services rather than margin, as our page on the Mounjaro UK no price increase situation explains in more detail. We'd rather be transparent about what our price covers than quietly thin the service to look cheaper.

One transparent fee at nume includes the consultation, the prescription, the medicine, next-working-day tracked delivery and clinical aftercare every day of the week. There are no add-ons, no subscription traps and no hidden prescription fees. A named prescriber reads your consultation the same day, not software making a binary pass/fail decision. That matters most if something changes: a side effect, a dose question, a new medication that could interact. Our clinical team is available when things aren't straightforward.

For context on where the injection pricing sits across the dose range, the Mounjaro injection price increase page breaks that down, including what the 5mg price increase means for patients moving into the mid-titration doses. Current treatment pricing at nume is shown on the treatment page.

For a prescription medicine, is cheapest the right question to ask?

It's worth being direct about this. Mounjaro is a prescription-only medicine. Under UK law (the Human Medicines Regulations 2012) it can only be dispensed following clinical assessment by a qualified prescriber. The MHRA has warned publicly about counterfeit weight-loss pens sold online, some containing insulin rather than tirzepatide, with real harm resulting. In 2025 alone, roughly 20 million doses of illegally traded weight-loss medicines (around £45 million worth) were seized by enforcement agencies.

A seller offering Mounjaro at a price far below the market rate, without asking for clinical information, or through social media without a verifiable pharmacy registration, is a red flag, not a bargain. Report any suspect seller at yellowcard.mhra.gov.uk.

Price matters, the September 2025 increase was steep and the frustration patients feel is legitimate. But the measure that actually keeps you safe is whether the supply chain is genuine, whether a qualified clinician reviewed your case, and whether there's real support if something goes wrong. That's the standard the nume pharmacy is built around, and you can verify our GPhC registration at registration number 9012878. Speak to our prescribers and see exactly what the process involves before committing to anything.